Efficacy of Combined Interferential Therapy and Electronic Cupping Therapy for Chronic Constipation Management

Launched by MIDDLE EAST UNIVERSITY · Sep 22, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment approach for chronic constipation, a condition where people have difficulty with bowel movements. The trial combines two therapies: interferential therapy, which uses gentle electrical signals to help stimulate the gut, and electronic cupping therapy, a technique that may enhance the effects of the first therapy. The goal is to see if this combination can improve bowel movements and overall digestive health for people who have struggled with constipation for a long time.

To be eligible for this trial, participants must have experienced chronic constipation for at least six months and have had two or fewer complete bowel movements per week. They should also feel like they haven't completely emptied their bowels during at least a quarter of their bathroom visits. However, individuals who are pregnant, have certain medical conditions, or have had specific surgeries may not qualify. Participants in the trial will receive the combined therapies and be monitored for improvements in their bowel habits. This study is currently active, but they are not recruiting new participants at this time.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • history of Chronic Constipation (CC), as defined by either experiencing two or fewer Complete Spontaneous Bowel Movements (CSBMs) per week for a minimum of 6 consecutive months before the screening visit
• • Reporting a sensation of incomplete evacuation or straining during at least a quarter of their bowel movements (according to the generally accepted definition of constipation).
• • Patients must have had CC persisting for more than 6 months, failed to respond to or be intolerant of medical treatment for at least 3 months
• Exclusion Criteria:
• • pregnant or lactating women
• • Chronic Constipation (CC) resulting from anorectal malformations such as colorectal or anal organic lesions, pelvic floor disorders requiring surgical intervention as determined by the investigator (such as rectal prolapse, rectocele, or enterocele)
• • presence of implanted electronic devices like cardiac pacemakers, defibrillators, cardiac pumps, or spinal stimulators
• • CC attributable to medications or neurologic, endocrine, or metabolic conditions
• • prior history of partial colectomy; conditions like megacolon, megarectum, or colonic inertia
• • skin abnormalities that hinder the placement of electrodes
• • women lacking adequate contraception (hormonal or intrauterine device).